α-Apo-Oxytetracycline, EvoPure®

α-Apo-Oxytetracycline, EvoPure®

Catalog Number:
M001342405TOK
Mfr. No.:
TOK-O009
Price:
$447
  • Size:
    100 mg
    Quantity:
    Add to Cart:
      • Overview
        • α-Apo-Oxytetracycline, EvoPure® (Oxytetracycline-related compound D) is an oxytetracycline metabolite and impurity found in commercial oxytetracycline. It is formed via acid hydrolysis of oxytetracycline. As an isomer of β-Apo-oxytetracycline, it forms readily in acidic and basic media. This highly pure metabolite can be used as a secondary reference standard during stability studies of oxytetracycline and can be used to study the degradation pathway and products of tetracyclines.
          α-Apo-Oxytetracycline, EvoPure® is very slightly soluble in water.

          Please contact us at for specific academic pricing.

          Background

          Oxytetracycline causes inhibition of protein synthesis. It binds to the 30S ribosomal subunit and prevents the amino-acyl tRNA from binding to the A site of the ribosome.

      • Properties
        • CAS Number
          18695-01-7
          Molecular Formula
          C22H22N2O8
          Molecular Weight
          442.42
          Solubility
          Very slightly soluble (0.2 mg/mL) in water
          Other Properties
          Source: Semi-synthetic
          Purity Level: >97.0%
          Storage
          -20°C

          * For research use only

      • Applications
        • Application Description
          Spectrum: Broad-spectrum, including Gram-negative and Gram-positive bacteria.

          Microbiology Applications: The fate of tetracyclines and their degradation products were studied under pH, chelation, and photodegradation. Tetracyclines photodecompose easily because they undergo direct photolysis and are converted to several products. Their potency to environmentally relevant sludge and soil bacteria is also a subject of investigation.

    Note: If you don't receive our verification email, do the following:

  • Copyright © Amerigo Scientific. All rights reserved.